Daily non-political popular news in brief.

Experimental weight-loss drug cuts appetite, burns more energy

The first clinical studies of an experimental drug have revealed that obese people who take it for 12 weeks lose weight, even at very low doses. Short-term studies also suggest that the drug, called taranabant -- the second drug designed to fight obesity by blocking cannabinoid receptors in the brain -- causes people to consume fewer calories and burn more energy.

Read more »

Keywords: experimental, weight-loss, drug, cuts, appetite, burns, energy, weight, loss, cut, burn

« Previous | Next »

Similar news on "Experimental weight-loss drug cuts appetite, burns more energy":

1. Low dose of serotonin-acting chemical improves blood sugar tolerance
   11-06-2007 · EurekAlert!
   An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press. Importantly, the researchers found, those effects of the drug occurred at a low dose that had no influence on feeding behavior, body weight, activity level, or energy expenditure.
   Similar news · Read more »
   
2. 'Exercise pill' switches on gene that tells cells to burn fat
   04-29-2007 · EurekAlert!
   By giving ordinary adult mice a drug -- a synthetic designed to mimic fat -- scientists are now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat. Even when the mice are not active, turning on the chemical switch activates the same fat-burning process that occurs during exercise. The resulting shift in energy balance (calories in, calories burned) makes the mice resistant to weight gain on a high fat diet.
   Similar news · Read more »
   
3. How to lose weight and not go hungry: HU researcher develops drug that mimics feeling of 'fullness'
   06-06-2007 · EurekAlert!
   Millions of people the world over suffer today from obesity, yet there is no "magic bullet" that has yet provided a universally accepted solution. However, a young researcher at the Hebrew University of Jerusalem feels he has come up with a practical weight loss solution for the obese person without his having to feel hungry.
   Similar news · Read more »
   
4. New drug makes weight loss safer
   09-26-2007 · EurekAlert!
   Dr. Nir Barak of TAU has adapted a well-known drug used to treat vertigo for a new purpose: to treat obesity without dangerous side effects.
   Similar news · Read more »
   
5. Popular ADHD drug safe and effective for pre-schoolers
   10-23-2006 · EurekAlert!
   A new study by researchers from the Johns Hopkins Children's Center and five other medical centers concludes that carefully measured, low doses of methylphenidate (Ritalin) are safe and effective for attention-deficit and hyperactivity disorder (ADHD) in preschoolers. Investigators warn, however, that three to five-year-olds appear more sensitive to the drug's side effects, which include irritability, insomnia and weight loss, than are older children with ADHD and require closer monitoring.
   Similar news · Read more »
   
6. Eggs promote weight loss and help close nutrient consumption gap
   05-02-2007 · EurekAlert!
   Nine studies presented at this week's Experimental Biology 2007 meeting support the growing body of research on the nutritional benefits of egg consumption, including its promotion of weight loss and its role in providing choline, an essential nutrient often lacking in the diet that promotes brain and memory development and function.
   Similar news · Read more »
   
7. Promising Antiobesity Drug Fails To Produce Clinically Meaningful Weight Loss
   10-05-2006 · ScienceDaily
   A drug designed to target a powerful hunger-stimulating factor that has long been considered a prime target for antiobesity therapy failed to produce clinically meaningful weight loss in obese people in a long-term clinical trial. People taking the drug known as MK-0557 for a year consistently lost about three pounds more than those taking a placebo, researchers reported in the October issue of the journal Cell Metabolism, published by Cell Press.
   Similar news · Read more »
   
8. Annals of Internal Medicine tip sheet for July 3, 2007, issue
   07-02-2007 · EurekAlert!
   In this issue: Dietary counseling results in weight loss of approximately six percent of body weight after one year; Annals of Internal Medicine is 80! -- Still young and still reaching out; High dose of cholesterol-lowering drug reduces risk for major cardiovascular events in older as well as younger patients; Beta-blockers reduce plaque in artery walls; and Cystatin C level predicts death risk from three causes as well as usual tests.
   Similar news · Read more »
   
9. Does OTC diet pill Alli live up to its name?
   06-13-2007 · EurekAlert!
   Alli is the first and only FDA-approved OTC product for weight loss. It is available in stores June 15. Dr. James Anderson, UK HealthCare weight loss researcher, studied the effects of the drug on mildly to moderately overweight individuals and found it does aid weight loss.
   Similar news · Read more »
   
10. Study identifies new regulator of fat metabolism
    06-05-2007 · EurekAlert!
    Over the past several years, animal studies have shown that high-fat, low-carbohydrate "ketogenic" diets cause demonstrable changes in metabolism and subsequent weight loss. Now, researchers at Beth Israel Deaconess Medical Center (BIDMC) have identified a key mechanism behind this turn of events. Their findings, which appear in the June 2007 issue of Cell Metabolism, demonstrate that a liver hormone known as FGF21 is required to oxidize fatty acids -- and thereby burn calories.
    Similar news · Read more »